Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3371-3371
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Tissue Eosinophils Threshold and its Association with Adult‐Onset Asthma in Chronic Rhinosinusitis
Patlada Kowatanamongkon, Kornkiat Snidvongs, Potjanee Korrungruang, et al.
International Forum of Allergy & Rhinology (2025)
Closed Access | Times Cited: 2
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis
Corrado Pelaia, Claudia Crimi, Alida Benfante, et al.
Respirology (2024) Vol. 29, Iss. 10, pp. 869-879
Open Access | Times Cited: 13
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?
Francesco Giombi, Gian Marco Pace, Francesca Pirola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 730-730
Open Access | Times Cited: 9
Clinical remission in severe asthma: lights and shadows on an ambitious goal
Corrado Pelaia, Eleonora Zannoni, Giovanni Paoletti, et al.
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 4, pp. 230-236
Closed Access | Times Cited: 5
Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes
Chongyang Zhao, Gang Wang, Li Zhang, et al.
Respiratory Medicine (2025) Vol. 240, pp. 108024-108024
Closed Access
Predictive significance of 15(S)-hydroxyeicosatetraenoic acid for eosinophilic chronic rhinosinusitis with nasal polyps
Ying Li, Bing Yan, Bangyu Cui, et al.
Asia Pacific Allergy (2025)
Open Access
Benralizumab and the integrated management of co‐morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps
Joaquim Mullol, Maria D’Amato, Eugenio De Corso, et al.
Clinical and Translational Allergy (2025) Vol. 15, Iss. 4
Open Access
Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps
Marco Caminati, Eugenio De Corso, Giancarlo Ottaviano, et al.
Current Allergy and Asthma Reports (2023) Vol. 24, Iss. 1, pp. 11-23
Open Access | Times Cited: 12
Proposal of a New Composite Score (DAMADECO) to Simultaneously Evaluate Asthma and CRSwNP Severity in Comorbid Patients
Maria D’Amato, Patrizio Pasqualetti, Elena Cantone, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 957-957
Open Access
Systemic barrier dysfunction in type 2 inflammation diseases: perspective in the skin, airways, and gastrointestinal tract
Juan Meng, Hao Xiao, Feng Xu, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Open Access
Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study
Luisa Brussino, Maria Aliani, Elena Altieri, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Asthma Phenotypes in the Era of Personalized Medicine
Víctor González-Uribe, Sergio Jesús Romero-Tapia, José A. Castro-Rodrı́guez
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6207-6207
Open Access | Times Cited: 7
Deletion of BRCC3 ameliorates airway inflammation in asthma by inhibiting the activation of NLRP3 inflammasome
Hao Wang, Yao Chen, Jin Zhang, et al.
International Immunopharmacology (2024) Vol. 145, pp. 113720-113720
Closed Access | Times Cited: 2
Effect of Obesity on the Expression of Genes Associated with Severe Asthma—A Pilot Study
Marina Bantulà, Ebymar Arismendi, Valeria Tubita, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4398-4398
Open Access | Times Cited: 4
Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab
Andrea Ledda, Giulia Costanzo, Giada Sambugaro, et al.
Life (2023) Vol. 13, Iss. 9, pp. 1884-1884
Open Access | Times Cited: 4
Do Comorbidities Influence the Response to Biologics in Severe Asthma?
Corrado Pelaia, Girolamo Pelaia, William W. Busse
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 3, pp. 233-235
Open Access | Times Cited: 4
Type 2 severe asthma: pathophysiology and treatment with biologics
Corrado Pelaia, J. Mark Melhorn, Timothy S.C. Hinks, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 7, pp. 485-498
Closed Access | Times Cited: 1
Asthma Phenotypes in the Era of Personalized Medicine
Víctor González-Uribe, Sergio Jesús Romero-Tapia, José A. Castro-Rodrı́guez
(2023)
Open Access | Times Cited: 3
The Bronchodilator Potential of Astragalus sarcocolla: An in vitro Experiment
Waqar Ahmed Siddiqui, Muniza Qayyum, Aamina Quddus Qureshi, et al.
Journal of College of Physicians And Surgeons Pakistan (2024) Vol. 34, Iss. 01, pp. 58-62
Open Access
Therapeutic physical factors in correction of systemic mechanisms of comorbidity in patients with polypous rhinosinusitis
T. G. Pelishenko, С. Н. Нагорнев, Н.Б. Корчажкина, et al.
Восстановительные биотехнологии, профилактическая, цифровая и предиктивная медицина. (2024) Vol. 1, Iss. 1, pp. 5-5
Closed Access
Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment
J. J. Ley-Tomas, A. M. Xicotencatl-Tellez, M. L. García-Cruz, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access
Fibroblast Growth Factor 21 Confers Protection Against Asthma Through Inhibition of NLRP3 Inflammasome Activation
Yudong Liu, Jingxian Li, Zhen-Yu Wu, et al.
Inflammation (2024)
Closed Access
The Effects of Mepolizumab on CRSwNP: Real-Life Evidence
Elena Cantone, B Cassiano, Paolo Pezzella, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 11, pp. 1112-1112
Open Access
Anticuerpos monoclonales en enfermedades alérgicas: Desarrollo, farmacología y aplicaciones clínicas
Selene Pury, Ricardo J Saranz, María José Irastorza, et al.
Revista de la Facultad de Ciencias Médicas de Córdoba (2024) Vol. 81, Iss. 4, pp. 804-823
Open Access
A personalized approach to medical rehabilitation for patients with rhinosinusitis with nasal polyps and comorbid asthma
T. G. Pelishenko, Л. С. Круглова, С. Н. Нагорнев, et al.
Russian Journal of Physiotherapy Balneology and Rehabilitation (2024) Vol. 23, Iss. 3, pp. 175-188
Open Access
Page 1 - Next Page

Scroll to top